SS Innovations International (NASDAQ:SSII – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.02) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $11.10 million for the quarter. SS Innovations International had a negative return on equity of 30.23% and a negative net margin of 28.54%.
SS Innovations International Stock Performance
NASDAQ:SSII traded down $0.11 during trading on Wednesday, reaching $4.00. The company’s stock had a trading volume of 63,429 shares, compared to its average volume of 77,982. The firm has a market cap of $800.52 million and a price-to-earnings ratio of -66.67. The firm has a 50 day moving average of $4.62 and a 200-day moving average of $5.36. SS Innovations International has a 12 month low of $3.02 and a 12 month high of $11.87.
Insider Buying and Selling at SS Innovations International
In other SS Innovations International news, CEO Srivastava Sudhir acquired 498,753 shares of SS Innovations International stock in a transaction on Friday, March 6th. The stock was purchased at an average price of $4.01 per share, for a total transaction of $1,999,999.53. Following the purchase, the chief executive officer directly owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. This trade represents a 0.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Adams acquired 300,000 shares of SS Innovations International stock in a transaction on Friday, March 6th. The stock was acquired at an average price of $3.99 per share, with a total value of $1,197,000.00. Following the purchase, the director directly owned 5,331,902 shares in the company, valued at approximately $21,274,288.98. This trade represents a 5.96% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 1,300,006 shares of company stock worth $5,196,999 in the last quarter.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of research firms recently commented on SSII. Weiss Ratings reissued a “sell (e+)” rating on shares of SS Innovations International in a research report on Tuesday, April 21st. Wall Street Zen lowered SS Innovations International from a “hold” rating to a “sell” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.
Get Our Latest Stock Report on SS Innovations International
About SS Innovations International
AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.
Further Reading
- Five stocks we like better than SS Innovations International
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
